Curated by the JDD Editors
Missed any of our January highlights? January is our Aesthetics issue and it’s packed with intriguing articles–start to dive in! Catch up with this curated roundup from the JDD Editors: Your guide to must-read articles for the derm community.
Editor’s Pick
Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists: A FAERS Database Analysis From 2018-2024, evaluates predictors of cutaneous adverse events using dulaglutide as a reference, with sex, age, and GLP-1 receptor agonist type as independent variables.
Regulatory Landscape of Regenerative Dermatology: Current Frameworks and Future Directions highlights the need for a nuanced understanding of product mechanisms of action and their implications for skin structure and function.
A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma reports encouraging results with the novel agent malassezin for the treatment of melasma.
Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation supports integration of thiamidol-based regimens into existing skin care routines for individuals with facial hyperpigmentation.
Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States assesses racial and ethnic differences in disease severity and access to treatment in clinical practice.
Sunless Tanners in Dermatology: A Review of Ingredients, Efficacy, and Safety Profiles emphasizes the dermatologist’s role in educating patients about ingredients, potential risks, and best practices for safe and effective use.
Combined Use of Relabotulinum Toxin A and NASHA Gel Skinbooster for Rejuvenation of the Upper Third of the Face demonstrates improvement in lateral eyebrow tail elevation with combination treatment.
Characterizing Safety Outcomes of a Dermal Filler: Injection Site and Timing Insights From the MAUDE Database evaluates and categorizes adverse events associated with Juvéderm Volbella injections.
Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis indicates that all surveyed private insurers provide coverage for botulinum toxin following failure of standard topical or oral therapies.
Regulatory Landscape of Regenerative Dermatology: Current Frameworks and Future Directions discusses the importance of understanding mechanisms of action and their clinical implications for regenerative dermatologic products.
Photodistributed Hyperpigmentation Associated With COVID-19 Vaccination aims to raise awareness of a rare but potentially cosmetically disfiguring adverse effect associated with COVID-19 vaccination.
